Method of treating hemolytic disease

Details for Australian Patent Application No. 2005209854 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Bell, Leonard; Rother, Russell P.

Agent Shelston IP

Pub. Number AU-B-2005209854

PCT Pub. Number WO2005/074607

Priority 10/771,552 03.02.04 US

Filing date 3 February 2005

Wipo publication date 18 August 2005

Acceptance publication date 20 January 2011

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/074607 Priority application(s): WO2005/074607

20 January 2011 Application Accepted

  Published as AU-B-2005209854

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209856-Test strip composition and method to measure cholesterol from low density lipoproteins

2005209845-Naphthalimide dosing by N-acetyl transferase genotyping